Long-Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European Countries.
- DOI
- 10.1002/pds.5866
- Published
- 2024 Jul
- Container
- Pharmacoepidemiology and drug safety
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1002/pds.5866,
title = {Long-Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European Countries.},
author = {Magyari M and Koechlin A and Duclos A and Kopp TI and Allaoui EM and Polazzi S and Seeldrayers P and Autier P},
year = {2024},
journal = {Pharmacoepidemiology and drug safety},
doi = {10.1002/pds.5866},
url = {https://doi.org/10.1002/pds.5866}
}RIS
TY - JOUR TI - Long-Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European Countries. AU - Magyari M AU - Koechlin A AU - Duclos A AU - Kopp TI AU - Allaoui EM AU - Polazzi S AU - Seeldrayers P AU - Autier P PY - 2024 JO - Pharmacoepidemiology and drug safety DO - 10.1002/pds.5866 UR - https://doi.org/10.1002/pds.5866 ER -
APA
M, M., A, K., A, D., TI, K., EM, A., S, P., P, S., & P, A. (2024). Long-Term Safety of Teriflunomide in Multiple Sclerosis Patients: Results of Prospective Comparative Studies in Three European Countries.. Pharmacoepidemiology and drug safety. https://doi.org/10.1002/pds.5866
Source records
- pubmed · retrieved 2026-09-24T23:24:14.410Z